Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine
- 31 July 1996
- Vol. 14 (10) , 1001-1008
- https://doi.org/10.1016/0264-410x(96)00020-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccineVaccine, 1996
- Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2Gene, 1993
- The 5C Protein of Neisseria meningitidis Is Highly Immunogenic in Humans and Induces Bactericidal AntibodiesThe Journal of Infectious Diseases, 1993
- Expression of an inaccessible P1.7 subtype epitope on meningococcal class 1 proteinsJournal of Medical Microbiology, 1993
- Effect of outer membrane vesicle vaccine against group B meningococcal disease in NorwayThe Lancet, 1991
- Characterization of the opa (class 5) gene family of Neisseria meningitidisMolecular Microbiology, 1991
- Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assayVaccine, 1989
- Meningococcal Disease: Still with UsClinical Infectious Diseases, 1983
- Immunologic Response of Man to Group B Meningococcal Polysaccharide VaccinesThe Journal of Infectious Diseases, 1972
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970